Pathstone Family Office’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $293K | Buy |
4,044
+1,782
| +79% | +$129K | ﹤0.01% | 1318 |
|
|
2023
Q2 | $168K | Hold |
2,262
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q1 | $120K | Sell |
2,262
-507
| -18% | -$27K | ﹤0.01% | 1120 |
|
|
2022
Q4 | $187K | Sell |
2,769
-6
| -0.2% | -$406 | ﹤0.01% | 1392 |
|
|
2022
Q3 | $346K | Buy |
2,775
+2,267
| +446% | +$283K | ﹤0.01% | 1186 |
|
|
2022
Q2 | $48.6K | Buy |
508
+4
| +0.8% | +$383 | ﹤0.01% | 1019 |
|
|
2022
Q1 | $82K | Buy |
504
+4
| +0.8% | +$651 | ﹤0.01% | 927 |
|
|
2021
Q4 | $166K | Buy |
+500
| New | +$166K | ﹤0.01% | 844 |
|